In the current study, we validated our findings in 2 GSCs with wtp53 (OPK161 and OPK49) and used TCGA to analyze the correlation between Txnrd1 and wtp53 or mutant TP53 in GBM patients’ datasets. This evidence concerns the gene TP53 and glioblastoma.